Compliance, built in.
Peptide medicine moves fast — and so do the rules. Onboard's compliance team keeps you ahead of HIPAA, state boards, and FDA posture, so your clinicians can focus on patients.
BAAs with every pharmacy partner, encrypted PHI at rest and in transit, role-based access, and audit logs across the platform.
State-by-state guardrails for telehealth, controlled substances, and peptide-specific rules — updated whenever a state board changes posture.
Every peptide on Onboard is sourced exclusively from FDA-registered 503B outsourcing facilities operating under cGMP standards, located in the United States. Documentation, inspection history, and sterility records on file for every partner.
Real-time monitoring of FDA shortage lists, draft guidance, and warning letters that affect peptide compounding.
Built-in workflow for documenting and routing adverse events to the appropriate pharmacy and authorities.
Patient records, prescriptions, and order history retained per state and federal requirements, with export on request.
Frequently asked
Is Onboard a pharmacy?
No. Onboard is a platform connecting licensed clinics with vetted compounding pharmacies. We do not dispense or prescribe.
Do you sign a BAA?
Yes. We sign a HIPAA Business Associate Agreement with every clinic partner before go-live.
How do you vet pharmacies?
We require current state licensure, recent inspection reports, sterility testing protocols, and a clean regulatory history. Partners are re-reviewed annually.
What happens if a peptide goes on the FDA's restricted list?
We notify affected partners immediately, pause new orders, and provide guidance on patient communication and alternatives.
Need our compliance package?
BAAs, SOC reports, pharmacy documentation, and state-by-state matrices — available to prospective partners on request.
Request compliance package